Tianjin Ringpu Bio-Technology Co.,Ltd. (SHE:300119)
China · Delayed Price · Currency is CNY 17.84
-0.12 (-0.67%)
Sep 10, 2026, 2:09 PM CST
SHE:300119 Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Revenue Revenue Growth | 3,411 | 3,398 | 3,070 | 2,709 | 2,084 | 2,007 |
Revenue Growth | 1.50% | 10.70% | 13.32% | 29.98% | 3.84% | 0.34% |
Gross Profit Gross Profit Growth | 1,360 | 1,395 | 1,250 | 1,182 | 1,010 | 1,038 |
Operating Income Operating Income Growth | 391.16 | 382.25 | 375.04 | 378.65 | 350.43 | 355.16 |
Net Income Net Income Growth | 348.1 | 400.51 | 300.72 | 453.59 | 346.7 | 412.78 |
Earnings Per Share EPS Growth | 0.77 | 0.88 | 0.65 | 0.98 | 0.75 | 1.03 |
EPS Growth | -11.10% | 34.93% | -33.24% | 30.69% | -27.00% | 2.02% |
| Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Veterinary Biological Products Veterinary Biological Products Growth | 1,475 | 1,324 | 1,073 | 1,031 | 1,060 |
Pharmaceutical Preparations and Active Pharmaceutical Ingredients Pharmaceutical Preparations and Active Pharmaceutical Ingredients Growth | 1,050 | 1,040 | 1,110 | 1,019 | 921.45 |
Pet Supply Chain Pet Supply Chain Growth | 781.78 | 633.43 | 460.14 | - | - |
Epidemic Control Services Epidemic Control Services Growth | 69.99 | 44.83 | - | - | - |
Other Other Growth | 21.78 | 28.22 | 65.86 | 34.46 | 25.58 |
Total Total Growth | 3,398 | 3,070 | 2,709 | 2,084 | 2,007 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Investments Cash & Investments Growth | 1,553 | 1,694 | 1,939 | 1,821 | 1,901 | 2,009 |
Total Debt Total Debt Growth | 1,616 | 1,460 | 1,381 | 897.03 | 877.68 | 738.99 |
Net Cash (Debt) Net Cash Growth | -63.19 | 233.57 | 557.7 | 924.34 | 1,024 | 1,270 |
Net Cash Growth | - | -58.12% | -39.66% | -9.70% | -19.40% | 816.50% |
Net Cash Per Share Net Cash Per Share Growth | -0.14 | 0.51 | 1.21 | 1.99 | 2.21 | 3.16 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 355.8 | 297.53 | 735.55 | 410.13 | 389.49 | 382.63 |
Capital Expenditures CapEx Growth | -184.08 | -176.1 | -185.34 | -251.66 | -372.43 | -305.88 |
Free Cash Flow Free Cash Flow Growth | 171.73 | 121.43 | 550.21 | 158.47 | 17.05 | 76.75 |
Free Cash Flow Growth | -65.59% | -77.93% | 247.21% | 829.28% | -77.78% | -40.63% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Gross Margin | 39.87% | 41.04% | 40.71% | 43.65% | 48.44% | 51.71% |
Operating Margin | 11.47% | 11.25% | 12.22% | 13.98% | 16.81% | 17.70% |
Pretax Margin | 11.73% | 13.85% | 12.00% | 21.08% | 19.85% | 24.30% |
Profit Margin | 10.20% | 11.79% | 9.80% | 16.74% | 16.63% | 20.57% |
FCF Margin | 5.03% | 3.57% | 17.92% | 5.85% | 0.82% | 3.82% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Dividend Per Share Dividend Per Share Growth | 0.400 | 0.400 | 0.300 | 0.400 | 0.300 | 0.350 |
Dividend Per Share Growth | 33.33% | 33.33% | -25.00% | 33.33% | -14.29% | -12.50% |
Dividend Yield | 2.31% | 2.18% | 1.69% | 2.59% | 1.74% | 1.60% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
PE Ratio | 23.43 | 21.28 | 28.17 | 16.70 | 24.90 | 27.13 |
Forward PE | 17.88 | 16.59 | 16.49 | 14.66 | 17.95 | 19.57 |
P/FCF Ratio | 47.49 | 70.19 | 15.40 | 47.80 | 506.25 | 145.88 |
PS Ratio | 2.39 | 2.51 | 2.76 | 2.80 | 4.14 | 5.58 |